FDANonrulemakingFDA-2025-N-2489
Who commented on this docket
Onshoring Manufacturing of Drugs and Biological Products; Public Meeting; Request for Comments
18 organizations filed 18 public comments on Onshoring Manufacturing of Drugs and Biological Products; Public Meeting; Request for Comments, at the Food and Drug Administration. The comment window closed 271d ago.
Organizations
18
Comments
18
RIN
—
Comment window
closed 271d ago
Commenters (18)
- Alliance for Regenerative Medicinetrade assoc.1 filing · confidence 85%
- American Society of Gene & Cell Therapytrade assoc.1 filing · confidence 85%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- AuriosX Inc.unverified attribution1 filing · confidence 70%
- BioProcess Resources LLCunverified attribution1 filing · confidence 70%
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
- Council on Strategic Riskstrade assoc.1 filing · confidence 85%
- Eli Lilly and Companyunverified attribution1 filing · confidence 70%
- Massachusetts Biotechnology Associationtrade assoc.1 filing · confidence 85%
- National Association of Manufacturers (NAM)trade assoc.1 filing · confidence 97%
- North Carolina Inc.unverified attribution1 filing · confidence 70%
- Pharma & Biopharma Outsourcing Associationtrade assoc.1 filing · confidence 85%
- Plano Pharmaceuticals Inc.unverified attribution1 filing · confidence 70%
- Plasma Protein Therapeutics Associationtrade assoc.1 filing · confidence 85%
- Premier Inc.unverified attribution1 filing · confidence 70%
- Sentio BioSciences LLCunverified attribution1 filing · confidence 70%
- The Ritedose Corporationunverified attribution1 filing · confidence 70%
- Ultragenyx Pharmaceutical Inc.unverified attribution1 filing · confidence 70%
Attribution is name-based and imperfect. regulations.gov data is public record.